Preclinical Development - Chemical - ADME

(M0930-02-11) A Novel Fed State Approach to the Application of the Developability Classification System

(M1030-02-11) A Pharmacokinetic Evaluation of Mitraciliatine, a Kratom Alkaloid in Rats

(M1130-02-11) CNS Delivery of Novel DNA Damage Response (DDR) Inhibitors for the Treatment of Brain Tumors

(W1230-02-07) Investigation of the Relationship between Product-Dose and Dermal Exposure of Lidocaine and Prilocaine from a Topical Cream Product Using Dermal Microdialysis

(W1230-02-11) Multiple-Dose Pharmacokinetics of Major Kratom Alkaloid, Mitragynine, in Rats

(T1330-02-11) Assessing Cutaneous Pharmacokinetics of Tazarotene Using Coherent Raman Imaging

(T1330-02-12) Fed State Intestinal Drug Solubility: The Behaviour of Acidic Drugs

(T1430-02-11) The Impact of Advanced Age on Bacterial Drug Degradation in the Lower Intestine and the Usefulness of Data in Fecal Material

(T1430-02-12) Pharmacokinetics and Biliary Excretion of a Freeze-Dried Paclitaxel Prodrug-Loaded Polymeric Micelle Delivery System